Clinical Validation of Predictive Procedural Planning Software in a Real‐World TAVI Population
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70252 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Anne-Sophie Claes und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Insufficiency, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Preprocedural virtual planning of transcatheter aortic valve implantation (TAVI) using FEops HEARTguide TM may reduce major TAVI complications.
Aims
(1) To compare morphometric aortic root measurements by FEops HEARTguide TM and GE software; (2) to validate the accuracy of FEops HEARTguide TM in predicting post‐TAVI paravalvular aortic regurgitation (AR) and new conduction abnormalities.
Methods
In 106 consecutive TAVI patients, aortic root dimensions essential for prosthesis sizing were measured using both GE software and FEops HEARTguide TM . FEops HEARTguide TM predictions were compared with the severity of post‐TAVI AR assessed by echocardiography, angiography, invasive hemodynamics, and the development of conduction abnormalities assessed by serial electrocardiography.
Results
Bland‐Altman analysis revealed smaller annulus perimeter, area and coronary artery ostia heights with FEops HEARTguide TM compared with GE software, leading to differences in prosthesis sizing in 23% of cases. Predicted AR was significantly higher in patients with moderate versus none/trace AR on echocardiography (14.3 vs. 2.8 mL/s, p = 0.006) and angiography (23.6 vs. 4.0 mL/s, p = 0.009), though overlap between adjacent AR grades was observed. Predicted AR did not significantly differ between patients with AR index < 25 and ≥ 25 (10.2 vs. 5.7 mL/s, p = 0.079). Contact pressure index was significantly higher in patients with new conduction abnormalities (17.5 vs. 10.0%, p = 0.006), despite overlap at patient level.
Conclusions
FEops HEARTguide TM generally underestimates aortic root dimensions compared with GE software, affecting prosthesis sizing in a substantial proportion of patients. While predictive at a population level, overlap in parameters predicted by FEops HEARTguide TM is encountered at an individual patient level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Antwerp, Antwerp, Belgium.
- Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.
- Department of Cardiac Surgery, Antwerp University Hospital, Edegem, Belgium.
- Department of Radiology, Antwerp University Hospital, Edegem, Belgium.
ORCID-Profile: Anne-Sophie Claes
Zitieren
APA
Claes, A. S., Paelinck, B., Rodrigus, I., Vandendriessche, T., Jardinet, T., De Roeck, F., Bosmans, J., & Van Herck, P. (2025). Clinical Validation of Predictive Procedural Planning Software in a Real‐World TAVI Population. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70252
Vancouver
Claes AS, Paelinck B, Rodrigus I, Vandendriessche T, Jardinet T, De Roeck F, et al. Clinical Validation of Predictive Procedural Planning Software in a Real‐World TAVI Population. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70252
BibTeX
@article{Claes2025,
author = {Claes, Anne-Sophie and Paelinck, Bernard and Rodrigus, Inez and Vandendriessche, Tom and Jardinet, Thomas and De Roeck, Frederic and Bosmans, Johan and Van Herck, Paul},
title = {Clinical Validation of Predictive Procedural Planning Software in a Real‐World TAVI Population},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70252}
}
EUVIMED